MedDataX Logo

Treatment Results on Patients With Debridement and Prosthesis Retention in the Hip

NCT ID: NCT00757445

Last Updated: 2008-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

105 participants

Study Classification

OBSERVATIONAL

Study Start Date

1997-01-31

Study Completion Date

2007-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study presents the investigators results on patients treated for infection in the implemented hip prosthesis. Debridement and prosthesis retention is the method, followed by antibiotic treatment. The investigators present treatment results, predisposing factors and microbiological data.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infection Debridement With Prosthesis Retention

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Antibiotic therapy Microbiological diagnosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infection in prothesis in hip treated with debridement and prosthesis retention

Exclusion Criteria

* Other technique
Minimum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sorlandet Hospital HF

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sorlandet Sykehus HF

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bjoern Waagsboe, MD

Role: PRINCIPAL_INVESTIGATOR

Sorlandet Hospital HF

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sorlandet Hospital HF

Kristiansand, Agder, Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Sorlandet Hospital HF

Identifier Type: -

Identifier Source: org_study_id